533 related articles for article (PubMed ID: 30285743)
1. High dissolved oxygen tension triggers outer membrane vesicle formation by Neisseria meningitidis.
Gerritzen MJH; Maas RHW; van den Ijssel J; van Keulen L; Martens DE; Wijffels RH; Stork M
Microb Cell Fact; 2018 Oct; 17(1):157. PubMed ID: 30285743
[TBL] [Abstract][Full Text] [Related]
2. Sulfate depletion triggers overproduction of phospholipids and the release of outer membrane vesicles by Neisseria meningitidis.
Gerritzen MJH; Martens DE; Uittenbogaard JP; Wijffels RH; Stork M
Sci Rep; 2019 Mar; 9(1):4716. PubMed ID: 30886228
[TBL] [Abstract][Full Text] [Related]
3. Continuous production of Neisseria meningitidis outer membrane vesicles.
Gerritzen MJH; Stangowez L; van de Waterbeemd B; Martens DE; Wijffels RH; Stork M
Appl Microbiol Biotechnol; 2019 Dec; 103(23-24):9401-9410. PubMed ID: 31676919
[TBL] [Abstract][Full Text] [Related]
4. Spontaneously released Neisseria meningitidis outer membrane vesicles as vaccine platform: production and purification.
Gerritzen MJH; Salverda MLM; Martens DE; Wijffels RH; Stork M
Vaccine; 2019 Nov; 37(47):6978-6986. PubMed ID: 31383485
[TBL] [Abstract][Full Text] [Related]
5. Cysteine depletion causes oxidative stress and triggers outer membrane vesicle release by Neisseria meningitidis; implications for vaccine development.
van de Waterbeemd B; Zomer G; van den Ijssel J; van Keulen L; Eppink MH; van der Ley P; van der Pol LA
PLoS One; 2013; 8(1):e54314. PubMed ID: 23372704
[TBL] [Abstract][Full Text] [Related]
6. Outer membrane vesicles as platform vaccine technology.
van der Pol L; Stork M; van der Ley P
Biotechnol J; 2015 Sep; 10(11):1689-706. PubMed ID: 26912077
[TBL] [Abstract][Full Text] [Related]
7. Improved OMV vaccine against Neisseria meningitidis using genetically engineered strains and a detergent-free purification process.
van de Waterbeemd B; Streefland M; van der Ley P; Zomer B; van Dijken H; Martens D; Wijffels R; van der Pol L
Vaccine; 2010 Jul; 28(30):4810-6. PubMed ID: 20483197
[TBL] [Abstract][Full Text] [Related]
8. Surface display of a borrelial lipoprotein on meningococcal outer membrane vesicles.
Salverda ML; Meinderts SM; Hamstra HJ; Wagemakers A; Hovius JW; van der Ark A; Stork M; van der Ley P
Vaccine; 2016 Feb; 34(8):1025-33. PubMed ID: 26801064
[TBL] [Abstract][Full Text] [Related]
9. Outer membrane vesicles (OMVs) and detoxified lipooligosaccharide (dLOS) obtained from Brazilian prevalent N. meningitidis serogroup B strains protect mice against homologous and heterologous meningococcal infection and septic shock.
Jessouroun E; da Silveira IF; Larangeira AP; Pereira S; Fernandes SA; Rabinovitch L; Frasch CE; Castro-Faria-Neto HC; Bozza PT
Vaccine; 2004 Jun; 22(20):2617-25. PubMed ID: 15193387
[TBL] [Abstract][Full Text] [Related]
10. Next-generation outer membrane vesicle vaccines against Neisseria meningitidis based on nontoxic LPS mutants.
van der Ley P; van den Dobbelsteen G
Hum Vaccin; 2011 Aug; 7(8):886-90. PubMed ID: 21785281
[TBL] [Abstract][Full Text] [Related]
11. Outer Membrane Vesicle Vaccine Platforms.
Micoli F; Adamo R; Nakakana U
BioDrugs; 2024 Jan; 38(1):47-59. PubMed ID: 37796436
[TBL] [Abstract][Full Text] [Related]
12. Truncated Core/NS3 Fusion Protein of HCV Adjuvanted with Outer Membrane Vesicles of Neisseria meningitidis Serogroup B: Potent Inducer of the Murine Immune System.
Hekmat S; Sadat SM; Aslani MM; Mahdavi M; Bolhassani A; Asgar Halvaee F; Ghahari SMM; Aghasadeghi MR; Siadat SD
Iran Biomed J; 2019 Jul; 23(4):235-45. PubMed ID: 30278608
[TBL] [Abstract][Full Text] [Related]
13. PmrC (EptA) and CptA Negatively Affect Outer Membrane Vesicle Production in Citrobacter rodentium.
Sinha A; Nyongesa S; Viau C; Gruenheid S; Veyrier FJ; Le Moual H
J Bacteriol; 2019 Apr; 201(7):. PubMed ID: 30670547
[TBL] [Abstract][Full Text] [Related]
14. Meningococcal Outer Membrane Vesicle Composition-Dependent Activation of the Innate Immune Response.
Zariri A; Beskers J; van de Waterbeemd B; Hamstra HJ; Bindels TH; van Riet E; van Putten JP; van der Ley P
Infect Immun; 2016 Oct; 84(10):3024-33. PubMed ID: 27481244
[TBL] [Abstract][Full Text] [Related]
15. Comparative proteome analysis of spontaneous outer membrane vesicles and purified outer membranes of Neisseria meningitidis.
Lappann M; Otto A; Becher D; Vogel U
J Bacteriol; 2013 Oct; 195(19):4425-35. PubMed ID: 23893116
[TBL] [Abstract][Full Text] [Related]
16. Modulation of the biological activities of meningococcal endotoxins by association with outer membrane proteins is not inevitably linked to toxicity.
Quakyi EK; Hochstein HD; Tsai CM
Infect Immun; 1997 May; 65(5):1972-9. PubMed ID: 9125592
[TBL] [Abstract][Full Text] [Related]
17. Outer membrane vesicles (OMV) production of Neisseria meningitidis serogroup B in batch process.
Santos S; Arauz LJ; Baruque-Ramos J; Lebrun I; Carneiro SM; Barreto SA; Schenkman RP
Vaccine; 2012 Sep; 30(42):6064-9. PubMed ID: 22867717
[TBL] [Abstract][Full Text] [Related]
18. Stability of mono- and trivalent meningococcal outer membrane vesicle vaccines.
Arigita C; Jiskoot W; Westdijk J; van Ingen C; Hennink WE; Crommelin DJ; Kersten GF
Vaccine; 2004 Jan; 22(5-6):629-42. PubMed ID: 14741154
[TBL] [Abstract][Full Text] [Related]
19. Outer membrane vesicles from group B Neisseria meningitidis delta gna33 mutant: proteomic and immunological comparison with detergent-derived outer membrane vesicles.
Ferrari G; Garaguso I; Adu-Bobie J; Doro F; Taddei AR; Biolchi A; Brunelli B; Giuliani MM; Pizza M; Norais N; Grandi G
Proteomics; 2006 Mar; 6(6):1856-66. PubMed ID: 16456881
[TBL] [Abstract][Full Text] [Related]
20. Development and characterisation of outer membrane vesicle vaccines against serogroup A Neisseria meningitidis.
Norheim G; Aase A; Caugant DA; Høiby EA; Fritzsønn E; Tangen T; Kristiansen P; Heggelund U; Rosenqvist E
Vaccine; 2005 May; 23(29):3762-74. PubMed ID: 15893613
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
